Research News Archives - Page 12 of 14

Dopamine’s hidden role

April 2, 2017

Dopamine’s role as a neurotransmitter is well-known. But another role seems to be neuromodulation leading to the reconfiguration of functional brain circuits. Results that support this hypothesis are described in a new paper by Prof. […]

Translational models of psychiatric disease

April 2, 2017

The group of Prof. Christopher Pryce, Center for Psychiatric Research, University of Zurich, and CNS Diseases Research, Boehringer Ingelheim (BI), Biberach, have established a new collaboration for the study of mouse models of major psychiatric […]

Learning to overcome ADHD

December 9, 2016

Neurofeedback may be used as an alternative or additional treatment for ADHD. Processes underlying this technique are, however, not fully understood. Prof. Daniel Brandeis and colleagues investigated effects of neurofeedback in ADHD patients using fMRI […]

The root of schizophrenia

December 9, 2016

According to the dysconnection theory, the root cause of schizophrenia lies in abnormal neuromodulatory regulation of NMDA receptors. In their recently published paper, Klaas Enno Stephan and colleagues check whether new scientific data support the […]

Blood brain barrier is stress-proof

September 10, 2016

The blood brain barrier (BBB) is critical for brain health. Dr. Johannes Bohacek and Martin Roszkowski of the Brain Research Institute wanted to know whether stress could cause BBB leakiness. Their findings show that even […]

Noise improves brain performance

September 10, 2016

Adding small amounts of random disturbances to the brain can make a weak visual signal stronger. Research by the group of Prof. Nicole Wenderoth has demonstrated that transcranial random noise stimulation can enhance sensory perception. […]

New projects with UCL Neuroscience

June 7, 2016

Within the partnership of ZNZ with UCL Neuroscience regular calls for joint seed projects are launched. Seed projects and workshops should pave the way for larger collaborations between the two partners. In the third round, […]

Reduced social pain with psilocybin

June 7, 2016

Psilocybin is a hallucinogen that induces an altered state of consciousness. This substance was used by Dr. Katrin Preller and colleagues to study the effects of social exclusion. In their paper, published in the May […]

Specific inhibition of Aβ formation

June 7, 2016

BACE1, the enzyme involved in amyloid formation, is an important therapeutic target for Alzheimer’s Disease. Blocking BACE1 has, however, led to severe side effects. Professor Lawrence Rajendran and colleagues have now shown a method to […]

The immune system in AD

June 7, 2016

Dr. Maria Teresa Ferretti was awarded a three-year research grant from the Synapsis foundation to study the role of the immune system in Alzheimer’s disease. Together with co-applicants Dr. Luka Kulic and Prof. Britta Engelhardt […]